Singapore General Hospital's Department of Pathology risk assessment tool

Phyllodes Tumour Recurrence Risk Assessment

Welcome to the Singapore General Hospital's Department of Pathology risk assessment tool for estimating a person’s recurrence free likelihood following a histologic diagnosis of breast phyllodes tumour.
This tool is based on a study undertaken at the Singapore General Hospital (Tan PH et al. J Clin Pathol. 2012 Jan;65(1):69-76.)
This tool was designed for use by healthcare professionals. If you are not a healthcare professional, you are encouraged to discuss the results with your doctor.   Please read the SGH Nomogram Terms of Use before proceeding with this tool.
Detailed information on this risk assessment tool is available [Definitions for nomogram].

Does the tumor show stromal cytologic atypia
How many mitoses are visible per 10 high powered fields?
Is there stromal overgrowth seen?
Are the margins histologically involved (positive)?


SGH Nomogram Terms of Use | Privacy Policy